SYDNEY, AUSTRALIA, March 10, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), is pleased…
Company maintains strong cash position of $189.7 millionSOUTH SAN FRANCISCO, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc.…
Laurie McGraw, Former Allscripts Executive, Joins the Augmedix Board of DirectorsSAN FRANCISCO, March 10, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc.…
Company to host conference call at 4:30 PM EST today, March 10, 2022SEATTLE and VANCOUVER, British Columbia, March 10, 2022…
– U.S. Food and Drug Administration (“FDA”) removed clinical hold on SEL-302 for the treatment of patients with methylmalonic acidemia…
BLACKSBURG, Va., March 10, 2022 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company developing novel, oral…
WARRINGTON, Pa., March 10, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused…
Innovative new robotic targeting and navigation system provides precision, accessibilityPALM BEACH GARDENS, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- Accelus,…
REDWOOD CITY, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic…
CAMBRIDGE, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel…